StockMacro
Menu

Rhythm Pharmaceuticals

$112.36 +25% in 6 monthsMarket cap $7.8B

RYTM on XNAS, Health Care, Rhythm Pharmaceuticals, Inc., job postings

Measures activity, not value. Not investment advice.

Quarterly revenue jumped 80% to $92.1M while twelve-month losses reached $193.8M.

  • BadShort interest at 17% of shares, 23.3 days to cover
  • GoodInstitutional holders rose 10%, from 298 to 328 in a quarter

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company engaged in the development and commercialization of therapies for patients with rare neuroendocrine diseases. The company is focused on advancing its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. In addition, it has two early-stage investigational MC4R agonists in clinical development, RM-718 and bivamelagon, designed not to cause hyperpigmentation. The company is also focused on advancing potential candidates for congenital hyperinsulinism. It currently operates in two business segments: the United States, which generates maximum revenue, and International.

Industry
Pharmaceutical preparations (Health Care)
Employees
414
Website
rhythmtx.com
Listed
Nasdaq, US
Last results
3 Nov 2026
Next results
expected around 8 Jan 2027 (an estimate: a year ago it reported on 9 Jan 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $92.1M, net loss $41.4M.
Quarter to 31 Dec 2021: revenue –, net income -$42.9MQuarter to 31 Mar 2022: revenue $1.5M, net income -$52.8MQuarter to 31 Mar 2022: revenue $1.5M, net income -$52.8MQuarter to 30 Jun 2022: revenue $9.1M, net income -$45.0MQuarter to 30 Jun 2022: revenue $9.1M, net income -$45.0MQuarter to 30 Sep 2022: revenue $4.3M, net income -$40.9MQuarter to 30 Sep 2022: revenue $4.3M, net income -$40.9MQuarter to 31 Dec 2022: revenue $8.8M, net income -$42.5MQuarter to 31 Dec 2022: revenue $8.8M, net income -$42.5MQuarter to 31 Mar 2023: revenue $11.5M, net income -$52.2MQuarter to 31 Mar 2023: revenue $11.5M, net income -$52.2MQuarter to 30 Jun 2023: revenue $19.2M, net income -$46.7MQuarter to 30 Jun 2023: revenue $19.2M, net income -$46.7MQuarter to 30 Sep 2023: revenue $22.5M, net income -$44.2MQuarter to 30 Sep 2023: revenue $22.5M, net income -$44.2MQuarter to 31 Dec 2023: revenue $24.2M, net income -$41.6MQuarter to 31 Dec 2023: revenue $24.2M, net income -$41.6MQuarter to 31 Mar 2024: revenue $26.0M, net income -$141.4MQuarter to 31 Mar 2024: revenue $26.0M, net income -$141.4MQuarter to 30 Jun 2024: revenue $29.1M, net income -$32.3MQuarter to 30 Jun 2024: revenue $29.1M, net income -$32.3MQuarter to 30 Sep 2024: revenue $33.3M, net income -$43.6MQuarter to 30 Sep 2024: revenue $33.3M, net income -$43.6MQuarter to 31 Dec 2024: revenue $41.8M, net income -$43.3MQuarter to 31 Dec 2024: revenue $41.8M, net income -$43.3MQuarter to 31 Mar 2025: revenue $32.7M, net income -$49.5MQuarter to 31 Mar 2025: revenue $32.7M, net income -$49.5MQuarter to 30 Jun 2025: revenue $48.5M, net income -$46.6MQuarter to 30 Jun 2025: revenue $48.5M, net income -$46.6MQuarter to 30 Sep 2025: revenue $51.3M, net income -$52.9MQuarter to 30 Sep 2025: revenue $51.3M, net income -$52.9MQuarter to 31 Dec 2025: revenue $57.3M, net income -$47.5MQuarter to 31 Dec 2025: revenue $57.3M, net income -$47.5MQuarter to 31 Mar 2026: revenue $60.1M, net income -$55.6MQuarter to 31 Mar 2026: revenue $60.1M, net income -$55.6MQuarter to 30 Jun 2026: revenue $71.3M, net income -$49.3MQuarter to 30 Jun 2026: revenue $71.3M, net income -$49.3MQuarter to 30 Sep 2026: revenue $92.1M, net income -$41.4MQuarter to 30 Sep 2026: revenue $92.1M, net income -$41.4M
31 Dec 2021RevenueNet incomeNet losstallest bar $141.4M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$92.1M-$41.4M
30 Jun 2026$71.3M-$49.3M
31 Mar 2026$60.1M-$55.6M
31 Dec 2025$57.3M-$47.5M
30 Sep 2025$51.3M-$52.9M
30 Jun 2025$48.5M-$46.6M
31 Mar 2025$32.7M-$49.5M
31 Dec 2024$41.8M-$43.3M
30 Sep 2024$33.3M-$43.6M
30 Jun 2024$29.1M-$32.3M
31 Mar 2024$26.0M-$141.4M
31 Dec 2023$24.2M-$41.6M
30 Sep 2023$22.5M-$44.2M
30 Jun 2023$19.2M-$46.7M
31 Mar 2023$11.5M-$52.2M
31 Dec 2022$8.8M-$42.5M
30 Sep 2022$4.3M-$40.9M
30 Jun 2022$9.1M-$45.0M
31 Mar 2022$1.5M-$52.8M
31 Dec 2021–-$42.9M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $280.7M $174.3M
Revenue growthRevenue of the last 12 months compared with the 12 months before. +61% +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$193.8M -$192.3M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$2.90 -$3.10
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 88.2% 89.4% 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -66.7% -107% -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -69.0% -110% -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -164% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $320.9M $416.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $102.7M $109.0M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$218.3M (net cash) -$307.1M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 1.2 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.27
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. 27.7 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 27.0 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 88.6 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Rhythm PharmaceuticalsRYTM (this company) $7.8Bloss27.7+61%-69.0%
Protagonist TherapeuticsPTGX $7.9B23.214.4+164%62.0%
Summit TherapeuticsSMMT $8.0Bloss–––
AlkermesALKS $7.6Bloss4.3+15%-0.0%
Kiniksa Pharmaceuticals InternationalKNSA $7.4B67.37.8+58%11.6%
Amneal PharmaceuticalsAMRX $7.4B55.22.3+8.9%4.2%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$18.4M

bought $0, sold $18.4M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+10%

328 13F filers vs 298

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

78.9M shares held by 13F filers (30 Sep 2026) of 69.3M outstanding (2 Nov 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

17%

11.7M shares sold short (30 Oct 2026) of 69.3M outstanding (2 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

23.3

11.7M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+6.1%

11.0M shares sold short in the report before, 11.7M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

35%

35% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 61%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+80%

$92.1M vs $51.3M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

35

35 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

18×

35 articles in the last 7 days; its usual week has 2.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Revenue $92.1M, 1.8× a year earlier

Price $112.36 on 20 Nov 2026, +12% over 12 months (12-month range $75.82 to $119.04)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $42.6M in the last 12 months (the 12 months before: -$35.5M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.
Revenue per quarter. Revenue $92.1M in the latest quarter, +80% on a year earlier.
Capital spending per quarter. Capital spending $953K in the latest quarter.
Institutional holders (13F filers). 328 13F filers reported holding it in the latest 13F quarter, +31% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
5 Nov 2026Sharp changeQuarterly revenue change: quarterly revenue change, 92.1M vs usual 49.9M (2026-09-30); 1.8x the same period a year earlier
14 Apr 2026Sharp changeShort interest spike: short interest spike, 7.6M vs usual 5.2M (2026-03-31); 1.6x the same period a year earlier
3 Apr 20268-K and other filingsDirector or officer change
3 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Dec 20258-K and other filingsDirector or officer change
19 Dec 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Mar 20258-K and other filingsA major agreement ended
31 Oct 2023Sharp changeShort interest spike: short interest spike, 11.8M vs usual 8.4M (2023-10-13); 1.5x the same period a year earlier
3 Oct 2023Sharp changeShort interest spike: short interest spike, 12.0M vs usual 8.2M (2023-09-15); 2.0x the same period a year earlier
29 Aug 2023Sharp changeShort interest spike: short interest spike, 11.0M vs usual 8.1M (2023-08-15); 2.0x the same period a year earlier
15 Aug 2023Sharp changeShort interest spike: short interest spike, 12.4M vs usual 8.1M (2023-07-31); 1.7x the same period a year earlier
8 Aug 2023Sharp changeQuarterly revenue change: quarterly revenue change, 19.2M vs usual 1.5M (2023-06-30); 2.1x the same period a year earlier
8 Aug 20238-K and other filingsDirector or officer change
3 Aug 20238-K and other filingsDirector or officer change
3 Aug 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
1 Aug 2023Sharp changeShort interest spike: short interest spike, 11.5M vs usual 8.0M (2023-07-14); 1.9x the same period a year earlier
18 Jul 2023Sharp changeShort interest spike: short interest spike, 11.0M vs usual 7.9M (2023-06-30); 3.5x the same period a year earlier
29 Nov 2022Sharp changeShort interest spike: short interest spike, 8.4M vs usual 4.0M (2022-11-15); 2.2x the same period a year earlier
15 Nov 2022Sharp changeShort interest spike: short interest spike, 8.4M vs usual 3.9M (2022-10-31); 2.1x the same period a year earlier
3 Nov 20228-K and other filingsA major agreement ended
1 Nov 2022Sharp changeShort interest spike: short interest spike, 7.6M vs usual 3.9M (2022-10-14); 2.0x the same period a year earlier
18 Oct 2022Sharp changeShort interest spike: short interest spike, 7.6M vs usual 3.9M (2022-09-30); 2.1x the same period a year earlier
27 Sep 2022Sharp changeShort interest spike: short interest spike, 6.0M vs usual 3.9M (2022-09-15); 1.6x the same period a year earlier
13 Sep 2022Sharp changeShort interest spike: short interest spike, 5.8M vs usual 3.9M (2022-08-31); 1.4x the same period a year earlier
30 Aug 2022Sharp changeShort interest spike: short interest spike, 5.6M vs usual 3.9M (2022-08-15); 1.3x the same period a year earlier
16 Aug 2022Sharp changeShort interest spike: short interest spike, 7.2M vs usual 3.9M (2022-07-29); 1.5x the same period a year earlier
2 Aug 2022Sharp changeShort interest spike: short interest spike, 5.9M vs usual 3.8M (2022-07-15); 1.4x the same period a year earlier
Insider net buying (open market)
Month from 1 Feb 2022: -$19K published
Month from 1 Apr 2022: -$11K published
Month from 1 Jul 2022: -$41K published
Month from 1 Aug 2022: -$335K published
Month from 1 Feb 2023: -$272K published
Month from 1 Apr 2023: -$16K published
Month from 1 Jul 2023: -$16K published
Month from 1 Aug 2023: -$314K published
Month from 1 Sep 2023: -$173K published
Month from 1 Nov 2023: -$2.3M published
Month from 1 Dec 2023: -$1.7M published
Month from 1 Feb 2024: -$4.6M published
Month from 1 Mar 2024: -$6.3M published
Month from 1 Apr 2024: -$15K published
Month from 1 May 2024: -$153K published
Month from 1 Jul 2024: -$889K published
Month from 1 Aug 2024: -$3.8M published
Month from 1 Sep 2024: -$4.8M published
Month from 1 Nov 2024: -$5.9M published
Month from 1 Feb 2025: -$2.4M published
Month from 1 Mar 2025: -$3.9M published
Month from 1 Apr 2025: -$2.3M published
Month from 1 May 2025: -$897K published
Month from 1 Jun 2025: -$9.2M published
Month from 1 Jul 2025: -$5.7M published
Month from 1 Aug 2025: -$3.6M published
Month from 1 Sep 2025: -$1.8M published
Month from 1 Oct 2025: -$1.9M published
Month from 1 Nov 2025: -$3.7M published
Month from 1 Dec 2025: -$372K published
Month from 1 Feb 2026: -$2.2M published
Month from 1 Mar 2026: -$503K published
Month from 1 May 2026: -$428K published
Month from 1 Jun 2026: -$3.7M published
Month from 1 Aug 2026: -$17.0M published
Month from 1 Sep 2026: -$11.8M published
Month from 1 Nov 2026: -$6.6M published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 3 published
Quarter from 1 Jan 2023: 1 published
Quarter from 1 Jul 2024: 1 published
Quarter from 1 Jan 2025: 2 published
Quarter from 1 Apr 2025: 1 published
Revenue per quarter
Quarter ended 31 Mar 2022: $1.5M, +4180% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $9.1M, +3209% on a year earlier; public on 2 Aug 2023
Quarter ended 30 Sep 2022: $4.3M, +317% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2022: $8.8M; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $11.5M, +666% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $19.2M, +112% on a year earlier; public on 2 Aug 2023
Quarter ended 30 Sep 2023: $22.5M, +425% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $24.2M, +176% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $26.0M, +126% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $29.1M, +51% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $33.3M, +48% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $41.8M, +73% on a year earlier; public on 1 Mar 2025
Quarter ended 31 Mar 2025: $32.7M, +26% on a year earlier; public on 8 May 2025
Quarter ended 30 Jun 2025: $48.5M, +67% on a year earlier; public on 6 Aug 2025
Quarter ended 30 Sep 2025: $51.3M, +54% on a year earlier; public on 5 Nov 2025
Quarter ended 31 Dec 2025: $57.3M, +37% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $60.1M, +84% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $71.3M, +47% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $92.1M, +80% on a year earlier; public on 4 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $68K, -19% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $127K, +958% on a year earlier; public on 4 May 2022
Quarter ended 30 Jun 2022: $60K, -76% on a year earlier; public on 4 Aug 2022
Quarter ended 30 Sep 2022: $95K, -10% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Mar 2023: $47K, -63% on a year earlier; public on 3 May 2023
Quarter ended 30 Sep 2023: $1K, -99% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2025: $953K; public on 27 Feb 2026
Institutional holders (13F filers)
31 Dec 2021 report: 91; public on 14 Feb 2022
31 Mar 2022 report: 103; public on 16 May 2022
30 Jun 2022 report: 89; public on 15 Aug 2022
30 Sep 2022 report: 96; public on 14 Nov 2022
31 Dec 2022 report: 110; public on 14 Feb 2023
31 Mar 2023 report: 122; public on 15 May 2023
30 Jun 2023 report: 113; public on 14 Aug 2023
30 Sep 2023 report: 134; public on 14 Nov 2023
31 Dec 2023 report: 159; public on 14 Feb 2024
31 Mar 2024 report: 159; public on 15 May 2024
30 Jun 2024 report: 158; public on 14 Aug 2024
30 Sep 2024 report: 170; public on 14 Nov 2024
31 Dec 2024 report: 196; public on 14 Feb 2025
31 Mar 2025 report: 223; public on 15 May 2025
30 Jun 2025 report: 220; public on 14 Aug 2025
30 Sep 2025 report: 250; public on 14 Nov 2025
31 Dec 2025 report: 274; public on 17 Feb 2026
31 Mar 2026 report: 277; public on 15 May 2026
30 Jun 2026 report: 298; public on 14 Aug 2026
30 Sep 2026 report: 328; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it reported revenue of $92.1M for the quarter ended 30 Sep 2026, 1.8× the same quarter last year.
  • Quarterly revenue change: reported revenue of $92.1M for the quarter ended 30 Sep 2026, 1.8× the same quarter last year Public on 5 Nov 2026.
  • Insider net buying (open market): Insiders sold a net $42.6M in the last 12 months (the 12 months before: -$35.5M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 4 sales, $18.4M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Nov 2026Joseph ShulmanChief Technical OfficerSellplanned in advance (10b5-1); after exercising options45,921$119.90$5.5MForm 4
18 Nov 2026Christophe JeanDirectorSellplanned in advance (10b5-1); after exercising options10,000$109.66$1.1MForm 4
14 Sep 2026David P MeekerPresident and CEOSellplanned in advance (10b5-1); after exercising options50,000$102.67$5.1MForm 4
1 Sep 2026Hunter C SmithChief Financial OfficerSellplanned in advance (10b5-1); after exercising options62,774$105.46$6.6MForm 4
17 Aug 2026Joseph ShulmanChief Technical OfficerSellplanned in advance (10b5-1); after exercising options5,079$119.75$608KForm 4
17 Aug 2026Alastair GarfieldChief Scientific OfficerSellplanned in advance (10b5-1)7,763$117.57$913KForm 4
14 Aug 2026Yann MazabraudEVP, Head of InternationalSellplanned in advance (10b5-1); after exercising options57,000$116.15$6.6MForm 4
14 Aug 2026Jennifer Kayden LeeEVP, Head of North AmericaSellplanned in advance (10b5-1); after exercising options75,834$117.38$8.9MForm 4

328 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 51 opened a position, 27 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Ra Capital Management, L.P.6.7M9.62%$634.8MNo change
BlackRock, Inc.6.0M8.62%$568.9M-182K-2.9%
Baker Bros. Advisors LP5.6M8.08%$533.6MNo change
JPMorgan Chase & Co3.6M5.13%$340.8M+905K+34%
Vanguard Portfolio Management LLC3.1M4.54%$299.8M+12K+0.4%
Primecap Management Co3.1M4.42%$291.8M-105K-3.3%
Vanguard Capital Management LLC3.0M4.33%$286.2M-5270%
State Street Corp2.6M3.81%$251.2M+65K+2.5%
Perceptive Advisors LLC2.5M3.65%$241.1M-54K-2.1%
Westfield Capital Management Co LP2.5M3.58%$236.2M+272K+12%

Company events

All 32 company events

In 12 months: 2 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
3 Apr 2026Director or officer change8-K
19 Dec 2025Director or officer change8-K
20 Mar 2025A major agreement ended8-K
16 Apr 2024Signed a major agreementSame filing: changed shareholder rights, changed its bylaws or fiscal year8-K
1 Apr 2024Signed a major agreementSame filing: sold shares privately8-K
29 Feb 2024Signed a major agreement8-K
4 Jan 2024Signed a major agreementSame filing: sold shares privately8-K
8 Aug 2023Director or officer change8-K

The 5 newest of 163 articles that name the company.

DateHeadlinePublisher
22 Nov 2026Royalty Pharma plc (RPRX) stock price, news, quote and historyYahoo Finance Australia
21 Nov 2026Wall Street Analysts Are Bullish on Top Healthcare PicksThe Globe and Mail
21 Nov 2026Kiniksa Pharmaceuticals International, plc (KNSA) Stock Price, News, Quote & HistoryYahoo! Finance Canada
21 Nov 2026JPMorgan’s Names Top Biotech Stocks By Investing.comInvesting.com Canada
20 Nov 2026META_TITLE_QUOTEYahoo Finance Australia
Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

8 Aug 2023confirmed

Confirmed across sources Filings + Financials and Short interest and volume

Rhythm Pharmaceuticals (RYTM): reported revenue of $19.2M for the quarter ended 30 Jun 2023, 2.1× the same quarter last year, while it had 12.4M shares sold short in the 31 Jul 2023 report, 1.7× the same report last year. Two unrelated kinds of activity within 42 days.

  • Short interest and volume: Short interest spike, became public on 13 Jul 2023
  • Short interest and volume: Short interest spike, became public on 26 Jul 2023
  • Financials: Quarterly revenue change, became public on 8 Aug 2023
  • Short interest and volume: Short interest spike, became public on 10 Aug 2023
  • Short interest and volume: Short interest spike, became public on 25 Aug 2023
2021-03-31: $35K2021-06-30: $274K2021-09-30: $1.0M2022-03-31: $1.5M2022-06-30: $9.1M2022-12-31: $8.8M2023-03-31: $11.5M2023-06-30: $19.2M
The quarter ended 30 Jun 2023 against the 7 quarters before it. this quarterearliernormal: $1.5M
See the evidence (5 changes)

Short interest and volume: Short interest spike became public on 13 Jul 2023

Rhythm Pharmaceuticals had 11.0M shares sold short in the 30 Jun 2023 report, 3.5× the same report last year.

This period
11.0M (the 30 Jun 2023 report)
Normal report (median of 24 earlier)
7.9M
Typical spread (median absolute deviation)
506K
How far from its usual level
+3.9
Same report last year
3.2M
History used
2,009 days
2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M
the 30 Jun 2023 report24 earlier reportsnormal: 7.9M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 26 Jul 2023

Rhythm Pharmaceuticals had 11.5M shares sold short in the 14 Jul 2023 report, 1.9× the same report last year.

This period
11.5M (the 14 Jul 2023 report)
Normal report (median of 24 earlier)
8.0M
Typical spread (median absolute deviation)
435K
How far from its usual level
+4.4
Same report last year
5.9M
History used
2,023 days
2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M
the 14 Jul 2023 report24 earlier reportsnormal: 8.0M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Financials: Quarterly revenue change became public on 8 Aug 2023

Rhythm Pharmaceuticals reported revenue of $19.2M for the quarter ended 30 Jun 2023, 2.1× the same quarter last year.

This period
$19.2M (the quarter ended 30 Jun 2023)
Normal quarter (median of 7 earlier)
$1.5M
Typical spread (median absolute deviation)
$1.5M
How far from its usual level
+8.2
Same quarter last year
$9.1M
History used
821 days
2021-03-31: $35K2021-06-30: $274K2021-09-30: $1.0M2022-03-31: $1.5M2022-06-30: $9.1M2022-12-31: $8.8M2023-03-31: $11.5M2023-06-30: $19.2M
the quarter ended 30 Jun 20237 earlier quartersnormal: $1.5M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Short interest and volume: Short interest spike became public on 10 Aug 2023

Rhythm Pharmaceuticals had 12.4M shares sold short in the 31 Jul 2023 report, 1.7× the same report last year.

This period
12.4M (the 31 Jul 2023 report)
Normal report (median of 24 earlier)
8.1M
Typical spread (median absolute deviation)
411K
How far from its usual level
+5.4
Same report last year
7.2M
History used
2,040 days
2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M
the 31 Jul 2023 report24 earlier reportsnormal: 8.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Short interest and volume: Short interest spike became public on 25 Aug 2023

Rhythm Pharmaceuticals had 11.0M shares sold short in the 15 Aug 2023 report, 2.0× the same report last year.

This period
11.0M (the 15 Aug 2023 report)
Normal report (median of 24 earlier)
8.1M
Typical spread (median absolute deviation)
413K
How far from its usual level
+3.5
Same report last year
5.6M
History used
2,055 days
2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M2023-08-15: 11.0M
the 15 Aug 2023 report24 earlier reportsnormal: 8.1M

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 5 Nov 2026Financials change

    reported revenue of $92.1M for the quarter ended 30 Sep 2026, 1.8× the same quarter last year.

    Same quarter last year: $51.3M; its normal quarter is $49.9M.

    See the evidence
    This period
    $92.1M (the quarter ended 30 Sep 2026)
    Normal quarter (median of 8 earlier)
    $49.9M
    Typical spread (median absolute deviation)
    $9.1M
    How far from its usual level
    +3.1
    Same quarter last year
    $51.3M
    History used
    2,009 days
    2024-09-30: $33.3M2024-12-31: $41.8M2025-03-31: $32.7M2025-06-30: $48.5M2025-09-30: $51.3M2025-12-31: $57.3M2026-03-31: $60.1M2026-06-30: $71.3M2026-09-30: $92.1M
    the quarter ended 30 Sep 20268 earlier quartersnormal: $49.9M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  2. 11 Apr 2026Short interest and volume change

    had 7.6M shares sold short in the 31 Mar 2026 report, 1.6× the same report last year.

    Same report last year: 4.7M; its normal report is 5.2M.

    See the evidence
    This period
    7.6M (the 31 Mar 2026 report)
    Normal report (median of 24 earlier)
    5.2M
    Typical spread (median absolute deviation)
    405K
    How far from its usual level
    +4.0
    Same report last year
    4.7M
    History used
    3,014 days
    2025-03-31: 4.7M2025-04-15: 5.1M2025-04-30: 4.9M2025-05-15: 5.1M2025-05-30: 4.8M2025-06-13: 4.8M2025-06-30: 4.9M2025-07-15: 4.8M2025-07-31: 4.5M2025-08-15: 4.7M2025-08-29: 5.0M2025-09-15: 5.2M2025-09-30: 5.6M2025-10-15: 5.6M2025-10-31: 5.2M2025-11-14: 5.5M2025-11-28: 5.5M2025-12-15: 5.6M2025-12-31: 6.2M2026-01-15: 6.3M2026-01-30: 6.2M2026-02-13: 6.0M2026-02-27: 6.3M2026-03-13: 6.5M2026-03-31: 7.6M
    the 31 Mar 2026 report24 earlier reportsnormal: 5.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 3 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  4. 3 Apr 2026Filings record

    Director or officer change

  5. 19 Dec 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  6. 19 Dec 2025Filings record

    Director or officer change

  7. 20 Mar 2025Filings record

    A major agreement ended

  8. 25 Oct 2023Short interest and volume change

    had 11.8M shares sold short in the 13 Oct 2023 report, 1.5× the same report last year.

    Same report last year: 7.6M; its normal report is 8.4M.

    See the evidence
    This period
    11.8M (the 13 Oct 2023 report)
    Normal report (median of 24 earlier)
    8.4M
    Typical spread (median absolute deviation)
    631K
    How far from its usual level
    +3.6
    Same report last year
    7.6M
    History used
    2,114 days
    2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M2023-08-15: 11.0M2023-08-31: 10.7M2023-09-15: 12.0M2023-09-29: 10.1M2023-10-13: 11.8M
    the 13 Oct 2023 report24 earlier reportsnormal: 8.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  9. 27 Sep 2023Short interest and volume change

    had 12.0M shares sold short in the 15 Sep 2023 report, 2.0× the same report last year.

    Same report last year: 6.0M; its normal report is 8.2M.

    See the evidence
    This period
    12.0M (the 15 Sep 2023 report)
    Normal report (median of 24 earlier)
    8.2M
    Typical spread (median absolute deviation)
    469K
    How far from its usual level
    +4.7
    Same report last year
    6.0M
    History used
    2,086 days
    2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M2023-08-15: 11.0M2023-08-31: 10.7M2023-09-15: 12.0M
    the 15 Sep 2023 report24 earlier reportsnormal: 8.2M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 25 Aug 2023Short interest and volume change

    had 11.0M shares sold short in the 15 Aug 2023 report, 2.0× the same report last year.

    Same report last year: 5.6M; its normal report is 8.1M.

    See the evidence
    This period
    11.0M (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    8.1M
    Typical spread (median absolute deviation)
    413K
    How far from its usual level
    +3.5
    Same report last year
    5.6M
    History used
    2,055 days
    2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M2023-08-15: 11.0M
    the 15 Aug 2023 report24 earlier reportsnormal: 8.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 10 Aug 2023Short interest and volume change

    had 12.4M shares sold short in the 31 Jul 2023 report, 1.7× the same report last year.

    Same report last year: 7.2M; its normal report is 8.1M.

    See the evidence
    This period
    12.4M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    8.1M
    Typical spread (median absolute deviation)
    411K
    How far from its usual level
    +5.4
    Same report last year
    7.2M
    History used
    2,040 days
    2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M
    the 31 Jul 2023 report24 earlier reportsnormal: 8.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 8 Aug 2023several at once

    reported revenue of $19.2M for the quarter ended 30 Jun 2023, 2.1× the same quarter last year, while it had 12.4M shares sold short in the 31 Jul 2023 report, 1.7× the same report last year. Two unrelated kinds of activity within 42 days.

    See the evidence (5 changes)

    Short interest and volume: Short interest spike became public on 13 Jul 2023

    Rhythm Pharmaceuticals had 11.0M shares sold short in the 30 Jun 2023 report, 3.5× the same report last year.

    This period
    11.0M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    7.9M
    Typical spread (median absolute deviation)
    506K
    How far from its usual level
    +3.9
    Same report last year
    3.2M
    History used
    2,009 days
    2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M
    the 30 Jun 2023 report24 earlier reportsnormal: 7.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 26 Jul 2023

    Rhythm Pharmaceuticals had 11.5M shares sold short in the 14 Jul 2023 report, 1.9× the same report last year.

    This period
    11.5M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    8.0M
    Typical spread (median absolute deviation)
    435K
    How far from its usual level
    +4.4
    Same report last year
    5.9M
    History used
    2,023 days
    2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M
    the 14 Jul 2023 report24 earlier reportsnormal: 8.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Financials: Quarterly revenue change became public on 8 Aug 2023

    Rhythm Pharmaceuticals reported revenue of $19.2M for the quarter ended 30 Jun 2023, 2.1× the same quarter last year.

    This period
    $19.2M (the quarter ended 30 Jun 2023)
    Normal quarter (median of 7 earlier)
    $1.5M
    Typical spread (median absolute deviation)
    $1.5M
    How far from its usual level
    +8.2
    Same quarter last year
    $9.1M
    History used
    821 days
    2021-03-31: $35K2021-06-30: $274K2021-09-30: $1.0M2022-03-31: $1.5M2022-06-30: $9.1M2022-12-31: $8.8M2023-03-31: $11.5M2023-06-30: $19.2M
    the quarter ended 30 Jun 20237 earlier quartersnormal: $1.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Short interest and volume: Short interest spike became public on 10 Aug 2023

    Rhythm Pharmaceuticals had 12.4M shares sold short in the 31 Jul 2023 report, 1.7× the same report last year.

    This period
    12.4M (the 31 Jul 2023 report)
    Normal report (median of 24 earlier)
    8.1M
    Typical spread (median absolute deviation)
    411K
    How far from its usual level
    +5.4
    Same report last year
    7.2M
    History used
    2,040 days
    2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M
    the 31 Jul 2023 report24 earlier reportsnormal: 8.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Short interest and volume: Short interest spike became public on 25 Aug 2023

    Rhythm Pharmaceuticals had 11.0M shares sold short in the 15 Aug 2023 report, 2.0× the same report last year.

    This period
    11.0M (the 15 Aug 2023 report)
    Normal report (median of 24 earlier)
    8.1M
    Typical spread (median absolute deviation)
    413K
    How far from its usual level
    +3.5
    Same report last year
    5.6M
    History used
    2,055 days
    2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M2023-07-31: 12.4M2023-08-15: 11.0M
    the 15 Aug 2023 report24 earlier reportsnormal: 8.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  13. 8 Aug 2023Financials change

    reported revenue of $19.2M for the quarter ended 30 Jun 2023, 2.1× the same quarter last year.

    Same quarter last year: $9.1M; its normal quarter is $1.5M.

    See the evidence
    This period
    $19.2M (the quarter ended 30 Jun 2023)
    Normal quarter (median of 7 earlier)
    $1.5M
    Typical spread (median absolute deviation)
    $1.5M
    How far from its usual level
    +8.2
    Same quarter last year
    $9.1M
    History used
    821 days
    2021-03-31: $35K2021-06-30: $274K2021-09-30: $1.0M2022-03-31: $1.5M2022-06-30: $9.1M2022-12-31: $8.8M2023-03-31: $11.5M2023-06-30: $19.2M
    the quarter ended 30 Jun 20237 earlier quartersnormal: $1.5M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  14. 8 Aug 2023Filings record

    Director or officer change

  15. 3 Aug 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 3 Aug 2023Filings record

    Director or officer change

  17. 26 Jul 2023Short interest and volume change

    had 11.5M shares sold short in the 14 Jul 2023 report, 1.9× the same report last year.

    Same report last year: 5.9M; its normal report is 8.0M.

    See the evidence
    This period
    11.5M (the 14 Jul 2023 report)
    Normal report (median of 24 earlier)
    8.0M
    Typical spread (median absolute deviation)
    435K
    How far from its usual level
    +4.4
    Same report last year
    5.9M
    History used
    2,023 days
    2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M2023-07-14: 11.5M
    the 14 Jul 2023 report24 earlier reportsnormal: 8.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 13 Jul 2023Short interest and volume change

    had 11.0M shares sold short in the 30 Jun 2023 report, 3.5× the same report last year.

    Same report last year: 3.2M; its normal report is 7.9M.

    See the evidence
    This period
    11.0M (the 30 Jun 2023 report)
    Normal report (median of 24 earlier)
    7.9M
    Typical spread (median absolute deviation)
    506K
    How far from its usual level
    +3.9
    Same report last year
    3.2M
    History used
    2,009 days
    2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M2022-11-30: 7.9M2022-12-15: 8.1M2022-12-30: 7.8M2023-01-13: 7.9M2023-01-31: 7.7M2023-02-15: 8.1M2023-02-28: 8.1M2023-03-15: 7.4M2023-03-31: 8.0M2023-04-14: 8.2M2023-04-28: 8.5M2023-05-15: 9.0M2023-05-31: 9.7M2023-06-15: 9.9M2023-06-30: 11.0M
    the 30 Jun 2023 report24 earlier reportsnormal: 7.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 26 Nov 2022Short interest and volume change

    had 8.4M shares sold short in the 15 Nov 2022 report, 2.2× the same report last year.

    Same report last year: 3.8M; its normal report is 4.0M.

    See the evidence
    This period
    8.4M (the 15 Nov 2022 report)
    Normal report (median of 24 earlier)
    4.0M
    Typical spread (median absolute deviation)
    567K
    How far from its usual level
    +5.2
    Same report last year
    3.8M
    History used
    1,782 days
    2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M2022-11-15: 8.4M
    the 15 Nov 2022 report24 earlier reportsnormal: 4.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 10 Nov 2022Short interest and volume change

    had 8.4M shares sold short in the 31 Oct 2022 report, 2.1× the same report last year.

    Same report last year: 3.9M; its normal report is 3.9M.

    See the evidence
    This period
    8.4M (the 31 Oct 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    476K
    How far from its usual level
    +6.3
    Same report last year
    3.9M
    History used
    1,767 days
    2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M2022-10-31: 8.4M
    the 31 Oct 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 3 Nov 2022Filings record

    A major agreement ended

  22. 26 Oct 2022Short interest and volume change

    had 7.6M shares sold short in the 14 Oct 2022 report, 2.0× the same report last year.

    Same report last year: 3.9M; its normal report is 3.9M.

    See the evidence
    This period
    7.6M (the 14 Oct 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    389K
    How far from its usual level
    +6.4
    Same report last year
    3.9M
    History used
    1,750 days
    2021-09-30: 3.7M2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M2022-10-14: 7.6M
    the 14 Oct 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 13 Oct 2022Short interest and volume change

    had 7.6M shares sold short in the 30 Sep 2022 report, 2.1× the same report last year.

    Same report last year: 3.7M; its normal report is 3.9M.

    See the evidence
    This period
    7.6M (the 30 Sep 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    274K
    How far from its usual level
    +9.3
    Same report last year
    3.7M
    History used
    1,736 days
    2021-09-15: 3.7M2021-09-30: 3.7M2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M2022-09-30: 7.6M
    the 30 Sep 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  24. 27 Sep 2022Short interest and volume change

    had 6.0M shares sold short in the 15 Sep 2022 report, 1.6× the same report last year.

    Same report last year: 3.7M; its normal report is 3.9M.

    See the evidence
    This period
    6.0M (the 15 Sep 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +5.5
    Same report last year
    3.7M
    History used
    1,721 days
    2021-08-31: 4.1M2021-09-15: 3.7M2021-09-30: 3.7M2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M2022-09-15: 6.0M
    the 15 Sep 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 13 Sep 2022Short interest and volume change

    had 5.8M shares sold short in the 31 Aug 2022 report, 1.4× the same report last year.

    Same report last year: 4.1M; its normal report is 3.9M.

    See the evidence
    This period
    5.8M (the 31 Aug 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +4.9
    Same report last year
    4.1M
    History used
    1,706 days
    2021-08-13: 4.4M2021-08-31: 4.1M2021-09-15: 3.7M2021-09-30: 3.7M2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M2022-08-31: 5.8M
    the 31 Aug 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 25 Aug 2022Short interest and volume change

    had 5.6M shares sold short in the 15 Aug 2022 report, 1.3× the same report last year.

    Same report last year: 4.4M; its normal report is 3.9M.

    See the evidence
    This period
    5.6M (the 15 Aug 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +4.4
    Same report last year
    4.4M
    History used
    1,690 days
    2021-07-30: 4.8M2021-08-13: 4.4M2021-08-31: 4.1M2021-09-15: 3.7M2021-09-30: 3.7M2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M2022-08-15: 5.6M
    the 15 Aug 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 10 Aug 2022Short interest and volume change

    had 7.2M shares sold short in the 29 Jul 2022 report, 1.5× the same report last year.

    Same report last year: 4.8M; its normal report is 3.9M.

    See the evidence
    This period
    7.2M (the 29 Jul 2022 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    266K
    How far from its usual level
    +8.6
    Same report last year
    4.8M
    History used
    1,673 days
    2021-07-15: 4.4M2021-07-30: 4.8M2021-08-13: 4.4M2021-08-31: 4.1M2021-09-15: 3.7M2021-09-30: 3.7M2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M2022-07-29: 7.2M
    the 29 Jul 2022 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 27 Jul 2022Short interest and volume change

    had 5.9M shares sold short in the 15 Jul 2022 report, 1.4× the same report last year.

    Same report last year: 4.4M; its normal report is 3.8M.

    See the evidence
    This period
    5.9M (the 15 Jul 2022 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    171K
    How far from its usual level
    +5.6
    Same report last year
    4.4M
    History used
    1,659 days
    2021-06-30: 3.8M2021-07-15: 4.4M2021-07-30: 4.8M2021-08-13: 4.4M2021-08-31: 4.1M2021-09-15: 3.7M2021-09-30: 3.7M2021-10-15: 3.9M2021-10-29: 3.9M2021-11-15: 3.8M2021-11-30: 3.7M2021-12-15: 3.8M2022-01-14: 3.9M2022-01-31: 4.1M2022-02-15: 4.4M2022-02-28: 4.6M2022-03-15: 4.8M2022-03-31: 3.7M2022-04-14: 3.7M2022-04-29: 3.4M2022-05-13: 3.1M2022-05-31: 3.6M2022-06-15: 3.7M2022-06-30: 3.2M2022-07-15: 5.9M
    the 15 Jul 2022 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 2 Sep 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  30. 2 Sep 2021Filings record

    Director or officer change

  31. 26 May 2021Short interest and volume change

    had 3.5M shares sold short in the 14 May 2021 report, 2.0× the same report last year.

    Same report last year: 1.8M; its normal report is 2.0M.

    See the evidence
    This period
    3.5M (the 14 May 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    261K
    How far from its usual level
    +3.9
    Same report last year
    1.8M
    History used
    1,232 days
    2020-05-15: 1.8M2020-05-29: 1.6M2020-06-15: 1.7M2020-06-30: 1.8M2020-07-15: 1.9M2020-07-31: 2.0M2020-08-14: 1.9M2020-08-31: 1.9M2020-09-15: 2.1M2020-09-30: 2.0M2020-10-15: 2.0M2020-10-30: 1.8M2020-11-13: 1.9M2020-11-30: 2.1M2020-12-15: 1.8M2020-12-31: 2.8M2021-01-15: 3.5M2021-01-29: 3.0M2021-02-12: 2.9M2021-02-26: 2.7M2021-03-15: 2.7M2021-03-31: 4.2M2021-04-15: 3.7M2021-04-30: 3.6M2021-05-14: 3.5M
    the 14 May 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 12 May 2021Short interest and volume change

    had 3.6M shares sold short in the 30 Apr 2021 report, 2.5× the same report last year.

    Same report last year: 1.4M; its normal report is 2.0M.

    See the evidence
    This period
    3.6M (the 30 Apr 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    225K
    How far from its usual level
    +5.0
    Same report last year
    1.4M
    History used
    1,218 days
    2020-04-30: 1.4M2020-05-15: 1.8M2020-05-29: 1.6M2020-06-15: 1.7M2020-06-30: 1.8M2020-07-15: 1.9M2020-07-31: 2.0M2020-08-14: 1.9M2020-08-31: 1.9M2020-09-15: 2.1M2020-09-30: 2.0M2020-10-15: 2.0M2020-10-30: 1.8M2020-11-13: 1.9M2020-11-30: 2.1M2020-12-15: 1.8M2020-12-31: 2.8M2021-01-15: 3.5M2021-01-29: 3.0M2021-02-12: 2.9M2021-02-26: 2.7M2021-03-15: 2.7M2021-03-31: 4.2M2021-04-15: 3.7M2021-04-30: 3.6M
    the 30 Apr 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 27 Apr 2021Short interest and volume change

    had 3.7M shares sold short in the 15 Apr 2021 report, 2.1× the same report last year.

    Same report last year: 1.7M; its normal report is 1.9M.

    See the evidence
    This period
    3.7M (the 15 Apr 2021 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    178K
    How far from its usual level
    +6.5
    Same report last year
    1.7M
    History used
    1,203 days
    2020-04-15: 1.7M2020-04-30: 1.4M2020-05-15: 1.8M2020-05-29: 1.6M2020-06-15: 1.7M2020-06-30: 1.8M2020-07-15: 1.9M2020-07-31: 2.0M2020-08-14: 1.9M2020-08-31: 1.9M2020-09-15: 2.1M2020-09-30: 2.0M2020-10-15: 2.0M2020-10-30: 1.8M2020-11-13: 1.9M2020-11-30: 2.1M2020-12-15: 1.8M2020-12-31: 2.8M2021-01-15: 3.5M2021-01-29: 3.0M2021-02-12: 2.9M2021-02-26: 2.7M2021-03-15: 2.7M2021-03-31: 4.2M2021-04-15: 3.7M
    the 15 Apr 2021 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 23 Apr 2021Filings record

    Director or officer change

  35. 13 Apr 2021Short interest and volume change

    had 4.2M shares sold short in the 31 Mar 2021 report, 2.1× the same report last year.

    Same report last year: 2.0M; its normal report is 1.9M.

    See the evidence
    This period
    4.2M (the 31 Mar 2021 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    162K
    How far from its usual level
    +9.2
    Same report last year
    2.0M
    History used
    1,188 days
    2020-03-31: 2.0M2020-04-15: 1.7M2020-04-30: 1.4M2020-05-15: 1.8M2020-05-29: 1.6M2020-06-15: 1.7M2020-06-30: 1.8M2020-07-15: 1.9M2020-07-31: 2.0M2020-08-14: 1.9M2020-08-31: 1.9M2020-09-15: 2.1M2020-09-30: 2.0M2020-10-15: 2.0M2020-10-30: 1.8M2020-11-13: 1.9M2020-11-30: 2.1M2020-12-15: 1.8M2020-12-31: 2.8M2021-01-15: 3.5M2021-01-29: 3.0M2021-02-12: 2.9M2021-02-26: 2.7M2021-03-15: 2.7M2021-03-31: 4.2M
    the 31 Mar 2021 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  36. 1 Apr 2021Insiders record

    Meeker David P (President and CEO) bought 10,000 shares of RYTM ($201,700) (dated 31 Mar 2021)

  37. 25 Mar 2021Short interest and volume change

    had 2.7M shares sold short in the 15 Mar 2021 report, 1.7× the same report last year.

    Same report last year: 1.6M; its normal report is 1.9M.

    See the evidence
    This period
    2.7M (the 15 Mar 2021 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    150K
    How far from its usual level
    +3.5
    Same report last year
    1.6M
    History used
    1,172 days
    2020-03-13: 1.6M2020-03-31: 2.0M2020-04-15: 1.7M2020-04-30: 1.4M2020-05-15: 1.8M2020-05-29: 1.6M2020-06-15: 1.7M2020-06-30: 1.8M2020-07-15: 1.9M2020-07-31: 2.0M2020-08-14: 1.9M2020-08-31: 1.9M2020-09-15: 2.1M2020-09-30: 2.0M2020-10-15: 2.0M2020-10-30: 1.8M2020-11-13: 1.9M2020-11-30: 2.1M2020-12-15: 1.8M2020-12-31: 2.8M2021-01-15: 3.5M2021-01-29: 3.0M2021-02-12: 2.9M2021-02-26: 2.7M2021-03-15: 2.7M
    the 15 Mar 2021 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  38. 16 Mar 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  39. 16 Mar 2021Filings record

    Director or officer change

  40. 10 Mar 2021Short interest and volume change

    had 2.7M shares sold short in the 26 Feb 2021 report, 1.2× the same report last year.

    Same report last year: 2.3M; its normal report is 1.9M.

    See the evidence
    This period
    2.7M (the 26 Feb 2021 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    150K
    How far from its usual level
    +3.7
    Same report last year
    2.3M
    History used
    1,155 days
    2020-02-28: 2.3M2020-03-13: 1.6M2020-03-31: 2.0M2020-04-15: 1.7M2020-04-30: 1.4M2020-05-15: 1.8M2020-05-29: 1.6M2020-06-15: 1.7M2020-06-30: 1.8M2020-07-15: 1.9M2020-07-31: 2.0M2020-08-14: 1.9M2020-08-31: 1.9M2020-09-15: 2.1M2020-09-30: 2.0M2020-10-15: 2.0M2020-10-30: 1.8M2020-11-13: 1.9M2020-11-30: 2.1M2020-12-15: 1.8M2020-12-31: 2.8M2021-01-15: 3.5M2021-01-29: 3.0M2021-02-12: 2.9M2021-02-26: 2.7M
    the 26 Feb 2021 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Showing the newest 40 of 86 entries; narrow the window or the kind of data to see older ones.

Not listed: 297 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001649904
Ticker
RYTM
Domain
rhythmtx.com
Employer name
Rhythm Pharmaceuticals, Inc. (1 unverified)
Hq location
MA|BOSTON|02116 (1 unverified)
Name
RHYTHM METABOLIC, INC., Rhythm Pharmaceuticals Canada Inc, Rhythm Pharmaceuticals France SAS, Rhythm Pharmaceuticals Germany GmbH and 9 more
Uei
G9KGU2YDQNU4
Wikidata
Q30269284
  • DOL H-1B labor condition applications and PERM certifications35 data points14 Feb 2022 to 27 Jul 2026
  • SEC Form 13F institutional holdings324 data points31 Dec 2017 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)141 records20 Jan 2017 to 3 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)678 data points31 Dec 2014 to 2 Nov 2026
  • SEC Form 4 insider transactions194 records, 480 data points6 Oct 2017 to 20 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards12 data points10 Jul 2015 to 8 Jul 2021